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Abstract
Summary Association of body mass index and hip fracture has been controversial. In this study, women with lowest and highest
body weight had the highest fracture incidence. A 25-year follow-up indicated that obesity associates with early hip fracture risk
and suggested increasing trend in normal-weight women at a later stage.
Introduction Obesity is a pandemic health issue. Its association with hip fracture risk remains controversial. We studied the long-
term relationship of body mass index and hip fracture incidence in postmenopausal women.
Methods The cohort of 12,715 Finnish women born in 1932–1941 was followed for 25 years, covering ages from 58 up to 83.
Fractures and deaths were obtained from national registries. Women were investigated in deciles of BMI as well as in WHO
weight categories (normal, overweight, or obese). The follow-up analysis was carried out in two age strata as “early” (58–
70 years) and “late” (> 70 years). Body weight information was updated accordingly. Femoral neck BMD was recorded for a
subsample (n = 3163). Altogether, 427 hip fractures were observed.
Results A higher risk of early hip fracture was observed in obese and normal-weight compared with overweight women with
hazard ratios (HRs) of 2.3 ((95%CI) 1.4–3.7) and 2.0 (1.3–3.1) while no difference was observed in late hip fracture risk between
the three WHO categories (log rank p = 0.14). All-cause mortality during the follow-up was 19.3%. Compared with normal
weight women, the obese women had a higher risk of death with an HR of 1.6 (1.4–1.8) and higher baseline BMD (p < 0.001).
Faster bone loss was observed in the obese compared with other women (p < 0.001).
Conclusion Obesity associates with earlier hip fracture and higher postfracture mortality. The obese women with low BMD have
clearly the highest risk of hip fracture. This combination increases hip fracture risk more than either of the factors alone. After
75 years of age, risk appears to increase more in normal weight women, but this trend is in need of further confirmation.
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Introduction
Obesity is a major cause for preventable morbidity and pre-
mature mortality [1, 2], while hip fracture has devastating
consequences for independence and quality of life. Both obe-
sity and hip fracture cause significant burden to health care
and represent high societal costs [3, 4]. Overall, the relation-
ship between obesity, bonemass, and fracture risk in the aging
population is a complex and rather contradicting topic de-
pending on fracture type, population, age, and degree of over-
weight investigated. Recent studies suggest that the incidences
of specific fracture types such as ankle and upper leg fractures
were higher, while wrist and hip fracture was lower in obese
compared with non-obese women [5]. These results also im-
ply that factors such as lifestyle, exposure to daily activities,
and comorbidities, rather than just body composition or bone
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mass, affect fracture risk. This is also supported by results
where increasing levels of physical activity have been associ-
ated with higher incidence of wrist fracture, but lower inci-
dence of hip fracture, in postmenopausal women [6, 7].
Up to a point, heavier individuals tend to have a higher BMD,
but association between obesity and fracture risk is more com-
plex. Key bone characteristics determining fracture risk appear to
scale better in proportion of lean, rather than fat or total body
mass [8]. This demonstrates the biomechanical nature of bones
adapting to muscle contraction loads rather than sheer body
weight itself. In obese women, the proportion of lean mass be-
comes an even smaller fraction of total body weight, further
deteriorating this relative association. In case of a fall, heavier
body weight also increases impact forces leading to injury which
may have an accumulative effect on certain fracture types.
However, bodyweightmay also associate with protective factors
such as increased subcutaneous padding and non-protective such
as slower responses to falling or different direction of falls [9].
The joint effects of age, health behavior, comorbidities, and
other competing events, such as higher mortality, are overlap-
ping with obesity. Some health disorders commonly seen with
obesity, such as type 2 diabetes (T2DM), seem to increase
fracture risk at the hip [10], proximal humerus, ankle, and up-
per leg [11, 12]. Paradoxically, obesity and T2DM also have a
positive association with BMD [13, 14]. This example of a
seeming conflict makes fracture risk estimation with BMD
alone prone to underestimation. It is challenging to make any
conclusive comparison of these findings. While it has been
shown that several clinical factors in addition to BMD or
BMI can independently predict fracture risk, very few long-
term follow-up studies focusing on obesity from the late middle
age up to old age have been conducted [15, 16]. It is uncertain
how obesity predicts postmenopausal hip fracture, its type, and
postfracture mortality. Our objective was to focus on the role of
obesity in the occurrence of postmenopausal hip fractures in a
long-term prospective cohort study covering up to 25 years.
Materials and methods
The study population consisted of the ongoing Kuopio
Osteoporosis Risk Factor and Prevention (OSTPRE) study
cohort. This population-based long-term follow-up study in-
cludes all the 14,220 Caucasian women born between 1932
and 1941 who lived in the Kuopio Province, Eastern Finland
in April 1989. A postal questionnaire was mailed to 14,120 of
these women at baseline in 1989 with 13,100 (92.8%)
responding. The follow-up questionnaires were mailed at 5-
year intervals (1994, 1999, 2004, 2009, and 2014) to women
who responded to the baseline enquiry and were alive at the
time. The response rate varied between 93% and 80%
throughout the study. The OSTPRE study was approved by
the Kuopio University Hospital Ethics Committee on 28
October 1986 and is performed in accordance with the ethical
standards of the Declaration of Helsinki. Informed consent has
been provided before the onset of each data collection.
Follow-up and baseline age
The final study sample (n = 12,715) consisted of women with
available height andweight information. Due to the 10-year age
range, women’s initial follow-up age in 1989 varied from 47 to
57 years. Therefore, start of the follow-up was age matched
according to women’s 58th birthday by using either the base-
line, 5th, or 10th year questionnaire information, whichever
closest. Correspondingly, the start of register follow-up period
was also matched at the 58-year birthday for both outcomes of
interest (hip fracture and death). The individual baseline day for
the analysis was set from the oldest to youngest women be-
tween 1 January 1990 and 31 December 1999, respectively.
Follow-up was terminated to end of the registry data (31
December 2014) or to the event of interest (hip fracture and
death) whichever occurred first. During the follow-up analysis,
women reached a mean (median) age of 77.9 (77.8) years over
a follow-up time of 18.3 (18.7) years. Hip fracture risk was
investigated in two separate age periods as early (58–70 years)
and late (> 70 years) due to non-proportional hazard between
the groups during the first half of the follow-up.
Bone mineral density measurements
Baseline responders were asked about their willingness to
participate in bone densitometry (DXA) and clinical measure-
ment protocols. Altogether, 11,055 women stated their will-
ingness, which formed a pool for a stratified random sample of
3686 women invited to the measurements. Out of these, 3222
women underwent the baseline DXA scan. This sample
consisted of a random population sample (n = 2025) and
100% samples (n = 1197) of women with higher risk profiles,
including menopause within 2 years, diseases, or medication
affecting bone, such as rheumatoid arthritis [17]. The DXA
subsample used in this study (n = 3163) consisted of women
with valid femoral neck bone densitometry at baseline 1989,
at 5th year or at 10th year follow-up, where closest matching
to 58 years of age was used as a baseline value. Subjects with
both baseline and 25-year BMD follow-up data available (n =
792) formed the subsample for proportional bone loss rate (%)
comparison between groups. Body composition follow-up da-
ta was not recorded at the time being. Femoral neck T-score
value was determined according to the Third National Health
and Nutrition Examination Survey (NHANES III) with refer-
ence to white women aged 20–29 years [18].
The BMD measurements were carried out using a Lunar
DPX scanner (Lunar, Madison, WI, USA) at both baseline
(1989) and 5th year follow-up (1994). The original scanner
was replaced with a DPX-IQ during the 10th year
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measurement in 1999. The manufacturer’s quality protocol
was followed daily. To reveal the agreement between the
scanners, 90 women were scanned with both instruments on
the same day. The use of patient measurements rather than
phantom measurements was emphasized. The long-term re-
producibility of the DXA scanner determined by phantom
measurements was 0.4% [1]. The detailed description of
OSTPRE clinical measurement follow-up protocol and DXA
cross-calibration has been published previously [6].
Body mass index
Bodymass index was calculated from self-reported height and
weight. The self-reported weight and measured weight have
previously shown a good level of agreement in postmeno-
pausal women and are considered reasonably reliable for
BMI calculations [19]. In this cohort, the baseline bodyweight
of the DXA subsample (n = 3163) showed a high correlation
(Pearson r = 0.97) between the self-reported (67.8 kg (SD
11.7)) and measured baseline values (68.8 kg (SD 11.9) which
persisted throughout the follow-up.
The BMI was categorized in two ways: first according to
the WHO definition (kg/m2) as normal weight (18.5–24.9),
overweight (25.0–29.9), and obese (30.0 or higher) and sec-
ond, BMI was modeled in deciles to represent the overall 25-
year hip fracture incidence. The hip fracture probability asso-
ciated with a given BMI level was calculated by dividing the
total number of hip fractures by the attributable follow-up time
in person years for each BMI decile.
Available weight and height information closest to the age
of 58 years were used as a baseline value to investigate BMI
and early hip fracture incidence between 58 and 70 years.
Correspondingly, self-reported weight at 70 years of age was
utilized to update the BMI information for late hip fracture
analysis. Both BMI values were determined by utilizing avail-
able follow-up information (baseline, 5th, 10th, 15th, 20th)
whichever was closest to the age of interest. The correlation
of baseline weight against the 5th and 10th year values was
0.92 and 0.87 with a mean weight increase of + 2.2 kg ((SD)
4.9) and + 3.3 kg (6.1) towards the latter, respectively. A small
proportion of women with low BMI (15.0–18.49, n = 59)
were excluded from the normal-weight category in the
WHO classification but are included to the lowest decile of
BMI presenting the overall incidence rate of hip fractures in
the 25-year follow-up.
Registry outcomes: fractures, causes of fracture, and
deaths
The cohort’s hip fracture information was obtained from the
nationwide Hospital Discharge Register data (HILMO) as
well as by postal enquiries sent to the participants (at 10, 15,
20, and 25 follow-up years). All self-reported hip fractures
during the years 1989–2014 were validated by cross-
checking patient records. The Finnish Hospital Discharge
Register has previously been shown to reliably identify virtu-
ally all hip fractures [20]. The relevant International
Classification of Diseases (ICD) codes were used to include
femoral neck, pertrochanteric, and subtrochanteric fractures
(ICD-10 S72.0–S72.2). Women with pathologic (e.g., metas-
tasis) and periprosthetic hip fractures were excluded. We have
previously shown that the number of hip fractures from the
register was significantly higher than the self-reported one.
Women who did not respond to the OSTPRE survey were
shown to have significantly higher hip fracture incidence. A
study based solely on self-reported hip fractures would have
resulted in biased risk estimates. Our previous validation
study showed self-reports lacking 38% of hip fractures in this
long-term follow-up [21].
External causes of hip fracture were categorized according
to the Finnish version of ICD-9 that was in use between 1987
and 1995 (E800–E999), and ICD-10 was used since 1996
(V01.0–Y96.9) into low- and high-energy categories.
Fractures due to road traffic crashes resulting in motor vehicle,
bicycle, or pedestrian injuries or due to a fall from a height of
1 m or over were regarded as high-energy trauma (ICD-9;
E803E, E882A, and ICD-10; V01–V89, W10, W11, W17,
W22). Fractures related to a fall on level, slip fall, or falling
from a height of less than 1 m were considered low-energy
trauma (ICD-9; E881A, E883A, E889A, and ICD-10; W00–
W06, W19). Events with missing or unspecified information
of trauma energy involved (such as stress fracture, intoxica-
tion, fire, complication) were categorized as unclear (ICD-9;
E929X, E979A, and ICD-10; X50, X57, XX58, X59, Y83).
Causes of death were recorded by a certified physician
according to the national adaptation of the ICD. The hip frac-
ture risk analysis was stopped at the end of available informa-
tion on time and cause of death from the National Causes of
Death Register (31 December 2014), which have previously
been shown to be accurate [22]. Survival analyses were car-
ried out based on all-cause mortality.
Statistical analyses
The 58th birthday formed the baseline for the analysis.
Depending on the outcome of interest, follow-up was termi-
nated on the date of death, hip fracture, or at the end of the
registry period in 31December 2014. Overall, hip fracture risk
for normal, overweight, and obese groups was estimated by
using Kaplan-Meier estimation with a mean (median) follow-
up time of 18.5 (19.0) years, 18.4 (18.8) years, and 17.7 (18.0)
years, respectively. Since proportional hazard assumption of
obese women was not met across the whole age, we split the
follow-up data in two age strata: from 58 to 70 years as “early”
and over 70 years as “late.” Cox proportional hazard regres-
sion model was used to estimate hazard ratios with their
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respective 95% CI in two follow-up sections. By using time-
dependent covariate analysis in Cox regression, a non-
proportional hazard was observed between the study groups
hip fracture rate during the first follow-up section from 58 to
70 years of age (p < 0.001). Difference between baseline char-
acteristics, distribution of fracture type, and trauma energy
were investigated using t test and chi-squared methods.
Overweight group was considered the reference for the prima-
ry analysis due to lowest incidence rate in hip fracture out-




The cohort consisted of 12,715 women with a mean (median)
follow-up time of 18.3 (18.7) years. The mean baseline BMI
was 26.7 kg/m2, where 39.6% (n = 5039) of the women had
normal body weight. Altogether, 0.5% (n = 59) of women
were underweight (BMI of 15.0–18.49) at baseline with five
hip fractures during the follow-up. At the age of 70 years, the
number of underweight women was 131. These women were
excluded from the normal-weight WHO category but are in-
cluded within the lowest BMI decile showing overall hip frac-
ture incidence. Corresponding proportions of overweight (n =
5082) and obese (n = 2535) women at baseline were 39.9%
and 19.9%, respectively (Table 1). Overall, lower weight gain
during the first 10 years was observed in the normal BMI
group ((mean, SD) + 2.5 kg, 4.7)) compared with overweight
(+ 3.2 kg, 5.7) and obese (+ 3.4 kg, 8.6) women (ANOVA
p < 0.001). Mean weight change according to the baseline
category did not show significant changes within groups dur-
ing the total follow-up as shown in Fig. 5 (Appendix). The
proportion (%) of observed crossover between BMI categories
according to the body weight set at 58 and 70 years of age are
presented in Table 2 (Appendix).
Hip fracture risk and mortality
Total follow-up time was 233,096 person-years, during which
427 women had a hip fracture with a crude incidence of 24.4
per 10,000 person years and a prevalence of 3.4% at the end of
Table 1 Baseline characteristics of the total study population (N = 12,715) and according to theWHO definition (kg/m2) as underweight (15.0–18.49),
normal weight (18.5–24.9), overweight (25.0–29.9), and obese (30.0 or higher) with their respective mean (SD) or proportion (%)












Age (year) 58.0 (0) 58.0 (0) 58.0 (0) 58.0 (0) 58.0 (0) ns
Height (cm) 161.1 (0.5) 162.4 (6.3) 161.4 (5.3) 161.1 (5.2) 160.8 (5.3) < 0.001
Weight (kg) 68.3 (11.9) 47.8 (5.6) 59.3 (5.7) 69.4 (6.4) 84.5 (11.2) < 0.001
BMI (kg/m2) 26.7 (4.5) 17.7 (0.8) 22.9 (1.5) 27.2 (1.4) 33.6 (38) < 0.001
Current smoker (%) 25.8 40.7 26.2 25.4 24.7 < 0.05
Postmenopausal (%) 93.4 93.2 93.6 93.4 93.0 ns
Hip fracture, n (%) 427 5 173 157 92
Femoral neck 296 (69.3) 3 (60.0) 126 (78.2) 104 (66.2) 63 (68.5) ns
Pertrochanteric 106 (24.8) 2 (40.0) 38 (22.0) 44 (28.0) 22 (23.9) ns
Subtrochanteric 25 (5.9) 0 9 (5.2) 9 (5.7) 7 (7.6) ns
Fracture energy, n (%)
Unclear 54 (12.6) 26 (14.6) 15 (9.6) 13 (14.1) ns
Low 341 (79.9) 5 (100) 140 (78.7) 129 (82.2) 72 (78.3) ns
High 32 (7.5) 12 (6.7) 13 (8.3) 7 (7.6) ns
Subsampleb n = 3163 n = 12 n = 1279 n = 1256 n = 616
Mean femoral neck BMD
(g/cm2)b
0.914 (0.127) 0.777 (0.102) 0.867 (0.119) 0.929 (0.118) 0.985 (0.122) < 0.001
Mean femoral neck T-score
(NHANES III)b
0.45 − 0.69 0.06 0.58 1.04 < 0.001
Mean bone loss in 25 years
(%)b,c
− 8.7 − 4.8 − 7.7 − 9.1 − 10.6 < 0.01
a Difference between groups (t test and chi-squared)
b Subjects with available baseline BMD data (n = 3163). Femoral neck BMD values and T-score according to NHANES III white women reference
c Subjects with 25-year BMD follow-up data available (n = 792) in underweight (n = 3), normal (n = 350), overweight (n = 319), and obese (n = 120)
groups
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the follow-up. The mean age at the time of hip fracture during
the study follow-up was 72.6 years (range 58.3–82.5). The
number of hip fractures and occurrence (%) among normal,
overweight, and obese women during the whole follow-up
were 173 (3.4%), 157 (3.1%), and 92 (3.6%). Higher mortality
in obese women affecting hip fracture risk as a competing
outcome was present. Regardless, their overall hip fracture
incidence rate was higher compared with overweight and
normal-weight categories during the follow-up with respec-
tive values of 18.5 ((95%CI) 15.9–21.4)), 16.8 (14.3–19.6),
and 20.5 (16.6–25.0) per 10,000 person years.
Overall, significantly higher hip fracture risk was observed
in the obese and normal-weight groups compared with over-
weight women during the first half of the follow-up before
70 years of age (Fig. 1). This early hip fracture risk in obese
and normal-weight women had hazard ratios (HRs) of 2.3
((95% CI) 1.4–3.7, p < 0.01) and 2.0 (1.3–3.1, p < 0.01) com-
pared with overweight category. During the latter half of the
follow-up (> 70 years), no difference (Kaplan-Meier curves,
log-rank, p = 0.14) was seen in fracture risk between the cat-
egories (Fig. 2). The overall incidence rate of hip fractures in
25 years according to BMI deciles suggested a non-linear
association between the two (Fig. 3).
Obese women were more prone to suffer a hip fracture at
younger age, while the respective age gap narrowed with
normal-weight category during aging. With a hip fracture
probability of 1%, 2%, and 4%, the observed age gap between
the lowest (overweight) and highest (obese) categories was
5.1, 2.1, and 1.3 years, respectively. In practice, obese women
reached their 1% probability at the age of 66.7 years of age,
while the respective age for the overweight group was 71.8.
The categories with their respective fracture probabilities and
ages are shown in Table 3 Appendix.
The highest all-cause mortality during the follow-up was
observed in obese women (25.5%, n = 646), followed by the
overweight (18.3%, n = 930) and normal-weight (17.2%, n =
876) categories. Overall, the respective age-adjusted hazard
ratio for death in obese women was 1.6 ((95% CI) 1.4–1.8)
compared with normal-weight women which had the lowest
hazard during the follow-up.
Fracture type and postfracture mortality
No difference was observed in distribution of hip fracture
types among femoral neck (69.3%), pertrochanteric (24.8%),
and subtrochanteric (5.9%) regions between the WHO BMI
groups. Out of 427 women who sustained a hip fracture, the
overall mortality during follow-up was 41% (175), whereas
121 (28.3%) of the women died within 5 years after the inci-
dent. Survival analysis showed a tendency towards a higher 5-
year postfracture mortality after hip fracture in the obese com-
pared with overweight women when adjusted for age at the
time of fracture, with a HR of 1.5 ((95% CI) 0.9–2.4, p = 0.1)
which, however, did not reach statistical significance in this
cohort.
Bone density
A stratified random sample of 3163 women available with
DXA data formed the subsample for additional risk analysis
with a mean BMD femoral neck T-score of + 0.45 according
to NHANES III reference. Increasing BMD value (g/cm2) and
Fig. 1 Cumulative probability of
“early” hip fracture at ages 58–70
according to baseline BMI for
normal (green), overweight (or-
ange), and obese (red) women
(Kaplan-Meier curves, log-rank,
p < 0.01)
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T-score was observed between normal, overweight, and obese
weight categories, with mean values of 0.866 (T-score 0.05),
0.929 (0.58), and 0.985 (1.04), respectively (ANOVA,
p < 0.001). The number of OSTPRE women with osteoporo-
sis at the baseline is previously known to be low since
NHANES III BMD cutoff values are lower than Finnish na-
tional values, with a corresponding number of osteoporotic
(n = 4), osteopenic (n = 254), or normal (n = 2905) women
[18]. Using national (Finnish) cutoff values, the proportion
would still have remained low with corresponding numbers
of 74, 524, and 2565 women, respectively [23]. However,
prevalent overweight in this cohort contributes to slightly el-
evated mean T-score. Overall, obese women belonging to the
lowest BMD tertile showed the highest hip fracture incidence
with a rate of 58.6 (27.2–111.2) per 10,000 person years
(Fig. 4).
Fig. 3 Cumulative number and
incidence rate of hip fractures (per
10,000 person years) in 25 years
according to baseline BMI
percentile. The highest and lowest
deciles are presented in groups of
5%
Fig. 2 Cumulative probability of
“late” hip fracture at ages 70–83
according to baseline BMI for
normal (green), overweight (or-
ange), and obese (red) women
(Kaplan-Meier curves, log-rank,
p = 0.14)
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Discussion
This prospective cohort study showed an association between
obesity and higher hip fracture incidence before 70 years of
age in postmenopausal women. Higher all-cause mortality in
obese women was a competing risk for hip fracture. At
70 years of age, obesity did not seem to be associated with
higher hip fracture rate in this cohort, whereas normal BMI
showed a tendency for faster increase in fracture rate after
around 77 years of age. Altogether, during the follow-up pe-
riod of 25 years, the highest age-matched hip fracture rate was
seen in the lowest 5th percentile of BMI, followed by the most
obese 95th percentile of women. This relationship between
hip fracture incidence and BMI resembles a non-linear asso-
ciation, where the leanest and most obese women share the
highest overall risk but at a different age.
The result is consistent with some of the previous findings
where either low or high BMI has been reported as a risk
factor for fractures [24, 25]. However, the association of
BMI and hip fracture also varies with age whichmight explain
some of the contradictive observations between BMI and frac-
ture risk in studies with relatively short follow-up, wide age
range, or both. In this study, light body weight and obesity
both increased fracture risk, suggesting that BMI follows a
non-linear relationship with hip fracture risk in postmenopaus-
al women and that the association is age specific. Thus, obe-
sity is associated with early hip fracture risk which is
surpassed by lean women at around 75 years of age.
Additional factors including hip fracture type, trauma en-
ergy, and 5-year postfracture mortality were also investigated
in BMI categories and deciles to reveal associations that might
explain previous obesity-related contradictions in hip frac-
tures. However, hip fracture by anatomical region of femoral
neck, pertrochanteric, and subtrochanteric types was not asso-
ciated with BMI. In addition, the trauma energy involved
appeared to be similar throughout the body weight distribu-
tion. A tendency towards higher age-adjusted 5-year postfrac-
ture mortality after hip fracture was detected in obese women.
Although this was approximately the same as the all-cause
mortality in obese women. Thus, a hip fracture event does
not appear to bring an additional effect on the already higher
mortality risk among the obese women compared with others.
The lowest fracture risk was seen in the overweight wom-
en. Previous studies have suggested that higher BMI modifies
the fracture risk at least through increased BMD due to some-
what greater skeletal loading. It also translates to higher im-
pact forces when falling and may offer greater impact absorp-
tion by subcutaneous soft tissue. In addition, muscle mass and
strength relate to BMI and affect bone strength. However,
difference in muscle mass explaining BMI variance is not
expected to play a significant role in this age range. Muscle
strength and lean mass should be considered separately since
both independently associate with postmenopausal BMD in
this cohort [26]. Subtle overweight in elderly is also shown to
associate with lower risk in other health outcomes such as
incidence of fatal cardiovascular event and slightly lower mor-
tality rate [27]. Thus, lower hip fracture risk in overweight
group may have similar trend with these outcomes that are
probably explained by factors such as lifestyle, nutrition, and
overall health.
In this study, obesity associated with both early hip fracture
risk and higher all-cause mortality. The impact of BMI on hip
fracture risk in the aging population is a complex and multi-
factorial topic. Numerous overlapping risk factors and com-
peting events such as comorbidities, poor health behavior, low
functional capacity, and excessive all-cause mortality com-
monly coexist with obesity [28–31]. Variation in these factors
alone produces a significant bias for fracture risk estimation.
Mortality in general is suggested to have stronger association
with BMI. Being overweight or obese in young adulthood
appears to increase this risk, as well as being underweight or
obese in later life [32]. Similar association between mortality
with low and high BMI in later life also aligns with the current
observation of hip fracture incidence. Altogether, the results
indicate a low hip fracture probability in overweight women
compared with normal and obese categories. A similar reduc-
tion associatedwith overweight women has also been reported
in all-cause mortality [33]. Obesity-related excess mortality is
shown to decline with age [34] which can also be observed
with the hip fracture probability.
The current study consists of a very long follow-up of a
homogenous sample of postmenopausal women. Living in the
same area (Kuopio province) with a rather narrow age range
(of 10 years) makes these findings better controlled but more
cohort specific. The mean hip fracture age is limited by the
follow-up duration. Thus, it is not comparable with population
mean age in hip fracture incidence, where limiting factors
such as follow-up duration, gender, or age are not present.
Fig. 4 A 25-year hip fracture incidence rate in a DXA subsample of 3163
women with a total of 100 hip fractures according to baseline BMI cate-
gory and BMD tertile. Cutoff values for BMD tertile are 0.855 g/cm2 and
0.963 g/cm2
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Previously, several large cohort studies and meta-analyses
have studied women’s BMI and osteoporotic fractures in age
ranges from 20 up to + 100 years. The results have been some-
what contradictory mainly suggesting that obesity might even
be associated with a lower hip fracture risk but may promote
some other osteoporotic fracture types which are mediated
partly through BMD [12, 35–37]. However, methodological
methodological variations such as study settings, type of frac-
tures, follow-up times, heterogeneity of study populations,
and age ranges make the overall association inconclusive. In
addition, the follow-up times have commonly been limited to
well under 10 years which makes any age and weight change-
specific projections problematic. This study aimed to investi-
gate long-term change in BMI and fracture risk while control-
ling for the same chronological age throughout the follow-up.
The baseline BMI and bone mass were determined accord-
ing to time at the age of 58 and updated at 70 years of age. This
approach was likely to set off the time between the most recent
weight information available and the baseline date up to a max-
imum of 2.5 years. Although no significant change in BMD or
BMI within this period was detected, the bias cannot be totally
excluded. However, it is very unlikely that the observed mean
change of 1 kg in body weight during any 2.5-year period
would cause systematic error resulting in biased hip fracture
or mortality estimates. In addition, the longitudinal BMD data
was only available for small subsample, which prevented more
robust statistical analyses controlling for possible interaction
between bone parameters and BMI during the follow-up.
In conclusion, obesity associates with early hip fracture risk
in postmenopausal women before 70 years of age. The risk is
increased in normal-weight women at a later stage. Thus, body
mass index shows a non-linear relationship with hip fracture
in postmenopausal women. Obese women with low BMD
have even higher probability of hip fracture than with either
of these risk factors alone. A tendency for a higher post hip
fracture mortality in obese women aligns with their higher all-
cause mortality. Obesity should be considered as a risk factor
for early hip fracture as well as mortality.
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